| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 151,514 | 129,608 | 100,224 | 165,593 | | Cost of Revenue | 118,898 | 109,894 | 76,521 | 123,862 | | | Gross Profit | 32,616 | 19,714 | 23,703 | 41,731 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,975 | 36,360 | 38,862 | 56,373 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,359) | (16,646) | (15,159) | (14,642) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (6,359) | (16,646) | (15,159) | (14,642) | | Interest Expense | 3,380 | 3,774 | 4,062 | 3,541 | | Income Before Tax | (9,739) | (20,420) | (19,221) | (18,183) | | Income Tax Expense | (559) | (151) | (4,881) | (7,094) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,180) | (20,269) | (14,340) | (11,089) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,180) | (20,269) | (14,340) | (11,089) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,180) | ($20,269) | ($14,340) | ($11,089) |
|
0.22% Nasdaq 0.00%
Income Statement
